insights_auto
Why is TNDM up 7.93%?
Dive Deeperchevron_right
TNDM:NASDAQ
Tandem Diabetes Care Inc
$19.05
arrow_upward
+7.93%(+1.40) 1D
$18.61
arrow_downward
-2.31% (-0.44)todayPre-market
Closed: Nov 4, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TNDM...
Open
$17.83
High
$19.28
Low
$17.83
Mkt. cap
1.33B
Avg. vol.
2.30M
Volume
202.00
52-wk high
$29.65
52-wk low
$12.26
EPS
-$0.93
Beta
1.59
Shares outstanding
69.58M
No. of employees
2K
Open
$17.83
High
$19.28
Low
$17.83
Mkt. cap
1.33B
Avg. vol.
2.30M
Volume
202.00
52-wk high
$29.65
52-wk low
$12.26
EPS
-$0.93
Beta
1.59
Shares outstanding
69.58M
No. of employees
2K
News stories
From web sources and news partners
The Chronicle-Journal
·
1 day ago
Tandem Diabetes (TNDM) reports earnings tomorrow: what to expect
Profile
Tandem Diabetes Care, Inc. is an American medical-device company that develops and markets insulin pumps, automated insulin delivery systems and diabetes-management software. Headquartered in San Diego, California, its principal pump platforms are the t:slim X2 and Tandem Mobi, both of which use the company's Control-IQ+ software with compatible continuous glucose monitors.
Tandem was founded in 2006 and introduced its first pump, the touchscreen t:slim, in 2012. The company became publicly traded on the Nasdaq in 2013. By the end of 2025 it reported an in-warranty user base of nearly 500,000 people in more than 25 countries and annual sales of $1.015 billion. Wikipedia
About Tandem Diabetes Care Inc
CEOJohn Sheridan
Employees2.5K
FoundedJan 2006
Headquarters-
SectorMedical device
Industry-
Websitetandemdiabetes.com